TLANDO Trademark

Trademark Overview

On Monday, June 24, 2019, a trademark application was filed for TLANDO with the United States Patent and Trademark Office. The USPTO has given the TLANDO trademark a serial number of 88487154. The federal status of this trademark filing is REGISTERED as of Tuesday, August 9, 2022. This trademark is owned by Lipocine Inc.. The TLANDO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of testosterone deficiency
tlando

General Information

Serial Number88487154
Word MarkTLANDO
Filing DateMonday, June 24, 2019
Status700 - REGISTERED
Status DateTuesday, August 9, 2022
Registration Number6815476
Registration DateTuesday, August 9, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 22, 2019

Trademark Statements

Description of MarkThe mark consists of two vertical nestled arcs slightly offset which precede the word "TLANDO".
Goods and ServicesPharmaceutical preparations for the treatment of testosterone deficiency
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 4, 2019
Primary Code005
First Use Anywhere DateWednesday, May 25, 2022
First Use In Commerce DateWednesday, May 25, 2022

Trademark Owner History

Party NameLIPOCINE INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSALT LAKE CITY, UT 84108
Party NameANTARES PHARMA, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEWING, NJ 08628
Party NameANTARES PHARMA, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressEWING, NJ 08628
Party NameLipocine Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84108
Party NameLipocine Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84108

Trademark Events

Event DateEvent Description
Wednesday, February 7, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 9, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 9, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, July 5, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, July 4, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 29, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 16, 2022USE AMENDMENT FILED
Thursday, June 16, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, June 15, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 15, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 11, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, December 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 28, 2021SOU EXTENSION 4 GRANTED
Wednesday, December 15, 2021SOU EXTENSION 4 FILED
Tuesday, December 28, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 15, 2021SOU TEAS EXTENSION RECEIVED
Saturday, June 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 17, 2021SOU EXTENSION 3 GRANTED
Thursday, June 17, 2021SOU EXTENSION 3 FILED
Thursday, June 17, 2021SOU TEAS EXTENSION RECEIVED
Saturday, December 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 17, 2020SOU EXTENSION 2 GRANTED
Thursday, December 17, 2020SOU EXTENSION 2 FILED
Thursday, December 17, 2020SOU TEAS EXTENSION RECEIVED
Friday, June 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 17, 2020SOU EXTENSION 1 GRANTED
Wednesday, June 17, 2020SOU EXTENSION 1 FILED
Wednesday, June 17, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, December 17, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 22, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 22, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 2, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 13, 2019ASSIGNED TO EXAMINER
Friday, July 5, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, July 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 27, 2019NEW APPLICATION ENTERED

Related Keywords

tlando deficiency testosterone treatment preparations pharmaceutical